ActoBio AG019 (L. lactis) and teplizumab
Principal Investigator
Kevan Herold | Yale School of Medicine | New Haven, CT
Locations
Texas Diabetes & Endocrinology P.A. | Austin,TX
University of Minnesota Health | Minneapolis,MN
Barry Reiner | Baltimore,MD
University of South Florida | Tampa,FL
University Diabetes and Endocrine Consultants | Chattnooga,TN
UZ Leuven | Leuven,
UZ Antwerpen | Edegem,
UZ Brussel | Brussels,
Avail Clinical Research | DeLand,FL
Alzohaili Medical Consultants | Dearborn, MI
Research Institute of Dallas | Dallas,FL
Riley Hospital for Childen at IU Health | Indianapolis,IN
University of Alabama | Birmingham,AL
Yale Center for Clinical Investigation | New Haven,CT
University of California, San Francisco | San Francisco,CA
University of Colorado | Aurora,CO
Coastal Metabolic Reseach Centre | Ventura,CA
Benroya Research Institute | Seattle,WA
University of Miami | Miami,FL
Children's Mercy Hospital | Kansas City,MO
Children's Hospital of Philadelphia | Philadelphia,PA
Sanford Children's Specialty Clinic | Sioux Falls,SD
Study Code
ITN829AI
Study Status
Complete